Premium cannabis brand company Orchid Ventures, Inc. (CSE:ORCD)(OTC:ORVRF) (“Orchid” or the “Company”) releases a letter from its CEO, Corey Mangold.

Dear Shareholders,

We operate every day focused on building an ever increasingly strong and profitable business, all serving to enhance shareholder value. Given the pace of change within the cannabis industry and its challenges, I thought it important to provide an update to all shareholders so everyone is aware of Orchid’s focus and resolved commitment, despite the headwinds of the past few months. We will also be holding a Shareholders Meeting on Monday, November 25 in Lake Forest, CA (see below for details) to review in more detail the current state of the business and our plans for the balance of Fiscal 2020.


Given recent developments in the Cannabis industry we have aligned our focus on a few key objectives. We are accelerating efforts in 1) new product development to diversify our portfolio; 2) expanding into new markets and developing a line of CBD products through e-commerce and select traditional trade channels; and 3) maintaining an agile and streamlined organization that continues to eye potentially valuable and strategic partnerships.


Our primary focus remains fixated on Orchid’s growth and strengthening our position in the marketplace. A little more than a month ago, Oregon placed a ban on vape cartridges containing botanical derived terpenes. This ban cut into our Oregon revenue until we were able to launch an entirely new line of vape cartridges containing only cannabis derived terpenes. This new product line began presales last week and hit the shelves of retailers in Oregon earlier this week. Our sales of this new product line have exceeded previous sales records for Orchid … we have sold nearly 90% of inventory in the first week of pre-sales. With the ban on botanical derived terpenes lifted last week by the Oregon Court of Appeals, we now have the opportunity to provide customers in Oregon with more product options, which will provide us with further revenue upside.


Orchid also experienced a slowdown in California sales given negative press relating to the issues with illegal vape products. In fact, the entire California vape category was down in sales for August and September versus year-to-date trends according to BDS. However, despite the challenges, year-over-year California sales in these two months remained up +8%. And Orchid’s business in this state has seen a significant increase in sales over the last 4 weeks, primarily from our new product launch activities, expanding our sales team, as well as lowering the wholesale price of our product to retailers. Additionally, we are finalizing development on a new line of CBD products, as well as launching additional cannabis products in the dispensary sales channel over the coming months.


When the vape ban in Oregon arose, it highlighted the importance of revenue diversification. Our product development team has excelled over the last couple of months by creating a portfolio strategy and finalizing the readiness of our initial new product diversification efforts, which we are in the process of launching. This has enabled us to capitalize on and strengthen our relationship with key, high volume retail partners along with successfully opening up new sales channels for our products. By responding quickly, we have stabilized the business and positioned Orchid for growth in the future.

Another key objective is to leverage our core competencies by expanding into new channels like ecommerce and traditional retail which will create additional revenue streams for our business. Our management team has over 20 years of ecommerce experience in developing platforms, marketing, conversion optimization, and fulfillment management. Accordingly, we will be developing our own ecommerce presence to focus on CBD sales, hardware sales, and other products that do not contain THC and can be shipped over state lines and internationally.


Our mission is to “Create the Highest Standards in Cannabis” and we intend to live up to this by developing high quality products that our customers can depend on. Despite the negative press around vape, the vape category remains large and continues to grow year-over-year. Consistent with our mission, all Orchid products are thoroughly tested to ensure that they meet our own high standards as well as all specific legal standards set by governing bodies in the states and countries where we do business. Importantly, we have never used any of the cutting agents suspected of causing vape-related illnesses in our products, and we perform emissions testing on our hardware in order to fully understand the performance of our products and the impact on the customer experience.


We compete in a very young and in many ways immature industry. But despite the downturn in the capital markets, the vape situation and the interference of black market influence on legitimate and legal businesses, I thought it important for you to know that Orchid is responding by focusing on our business plans and growth priorities for the remainder of Fiscal 2020. We have momentum on various fronts and we remain confident in our ability to achieve our revenue and profit commitments.

Most in the industry have taken some body shots and are dealing with many of the same obstacles. We should expect further peaks and valleys in the days and months ahead as the industry continues to grow and mature. We are fully aware of this and believe that our experience, dedication and importantly the strength of the Orchid brand and our many loyal customers will get us through any adversity that may come our way.

I remain optimistic about Orchid’s future and I am excited about the challenges and opportunities that lie ahead. You can be assured that our executives and their teams are taking an offensive approach and diligently working to build on our growth trajectory. We will demonstrate, through solid financial performance and a focus on ethical business practices that we are moving in the right direction and adding value to our key constituents: Orchid customers, employees, shareholders and business partners.


We would like to invite all shareholders to a shareholder update meeting. Details are below.


Monday November 25th
6:00 pm PST


Orchid Corporate Headquarters
9930 Irvine Center Drive
Lake Forest, CA 92630

Snacks and beverages will be available


Corey R. Mangold
CEO, Founder & Director


Orchid Essentials is an Irvine, Calif.-based brand that launched in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium vape products. Orchid’s product lines are currently sold in 350+ dispensaries across California and Oregon and are handcrafted and designed for maximum flavor and overall enjoyment. The company’s proven processes and passion for what it does carry through into its products. The end result is an unparalleled experience for new and practiced cannabis users alike. Orchid plans to expand its brand into new national markets, as well as global markets such as Latin America and Europe. With a continued focus on brand and intellectual property development, Orchid will execute strategic acquisitions to solidify an integrated cannabis manufacturing and distribution infrastructure with the goal of becoming a dominant premium cannabis brand in the United States. Orchid’s management brings significant branding, product development and distribution experience with a proven track record of scaling revenues, building value-generating partnerships and creating enterprise value. Learn more at


Orchid Ventures, Inc.

Corey Mangold,
CEO, Founder & Director



Cautionary Statement Regarding “Forward-Looking” Information

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon.. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

Click here to connect with Orchid Ventures Inc. (CSE:ORCD, OTC:ORVRF) for an Investor Presentation.


Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less